| 000 | 01694 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515212147.0 | ||
| 264 | 0 | _c20100928 | |
| 008 | 201009s 0 0 eng d | ||
| 022 | _a1432-0533 | ||
| 024 | 7 |
_a10.1007/s00401-010-0669-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGomez, Anna | |
| 245 | 0 | 0 |
_aInvolvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment. _h[electronic resource] |
| 260 |
_bActa neuropathologica _cAug 2010 |
||
| 300 |
_a155-67 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCerebral Cortex _xpathology |
| 650 | 0 | 4 |
_aCognition Disorders _xetiology |
| 650 | 0 | 4 |
_aElectrophoresis, Gel, Two-Dimensional _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlial Fibrillary Acidic Protein _xmetabolism |
| 650 | 0 | 4 |
_aGlycine _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLeucine-Rich Repeat Serine-Threonine Protein Kinase-2 |
| 650 | 0 | 4 |
_aMalondialdehyde _xmetabolism |
| 650 | 0 | 4 |
_aMass Spectrometry _xmethods |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 |
_aParkinson Disease _xcomplications |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xgenetics |
| 650 | 0 | 4 | _aReceptor for Advanced Glycation End Products |
| 650 | 0 | 4 |
_aReceptors, Immunologic _xmetabolism |
| 650 | 0 | 4 |
_aSerine _xgenetics |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 |
_aalpha-Synuclein _xmetabolism |
| 700 | 1 | _aFerrer, Isidre | |
| 773 | 0 |
_tActa neuropathologica _gvol. 120 _gno. 2 _gp. 155-67 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00401-010-0669-y _zAvailable from publisher's website |
| 999 |
_c19598031 _d19598031 |
||